138 related articles for article (PubMed ID: 15292480)
21. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations.
Haller CA; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2005 Jun; 77(6):560-71. PubMed ID: 15961987
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
Shekelle PG; Hardy ML; Morton SC; Maglione M; Mojica WA; Suttorp MJ; Rhodes SL; Jungvig L; Gagné J
JAMA; 2003 Mar; 289(12):1537-45. PubMed ID: 12672771
[TBL] [Abstract][Full Text] [Related]
23. The Acute Effects of Nonstimulant Over-the-Counter Dietary Herbal Supplements on Resting Metabolic Rate.
Salacinski AJ; Howell SM; Hill DL; Mauk SM
J Diet Suppl; 2016; 13(4):368-77. PubMed ID: 26317375
[TBL] [Abstract][Full Text] [Related]
24. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
Molnár D; Török K; Erhardt E; Jeges S
Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1573-8. PubMed ID: 11126208
[TBL] [Abstract][Full Text] [Related]
26. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.
Astrup A; Madsbad S; Breum L; Jensen TJ; Kroustrup JP; Larsen TM
Lancet; 2008 Nov; 372(9653):1906-1913. PubMed ID: 18950853
[TBL] [Abstract][Full Text] [Related]
27. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.
Kalman D; Incledon T; Gaunaurd I; Schwartz H; Krieger D
Int J Obes Relat Metab Disord; 2002 Oct; 26(10):1363-6. PubMed ID: 12355332
[TBL] [Abstract][Full Text] [Related]
28. A Comparative Study Examining the Impact of a Protein-Enriched Vs Normal Protein Postoperative Diet on Body Composition and Resting Metabolic Rate in Obese Patients after Sleeve Gastrectomy.
Schiavo L; Scalera G; Pilone V; De Sena G; Quagliariello V; Iannelli A; Barbarisi A
Obes Surg; 2017 Apr; 27(4):881-888. PubMed ID: 27677487
[TBL] [Abstract][Full Text] [Related]
29. Effects of carbohydrate quantity and glycemic index on resting metabolic rate and body composition during weight loss.
Karl JP; Roberts SB; Schaefer EJ; Gleason JA; Fuss P; Rasmussen H; Saltzman E; Das SK
Obesity (Silver Spring); 2015 Nov; 23(11):2190-8. PubMed ID: 26530933
[TBL] [Abstract][Full Text] [Related]
30. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
Muls E; Kolanowski J; Scheen A; Van Gaal L;
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
[TBL] [Abstract][Full Text] [Related]
31. The effect of an herbal dietary supplement containing ephedrine and caffeine on oxygen consumption in humans.
Greenway FL; Raum WJ; DeLany JP
J Altern Complement Med; 2000 Dec; 6(6):553-5. PubMed ID: 11152061
[TBL] [Abstract][Full Text] [Related]
32. An assessment of the thermogenic effects of fluoxetine in obese subjects.
Stinson JC; Murphy CM; Andrews JF; Tomkin GH
Int J Obes Relat Metab Disord; 1992 May; 16(5):391-5. PubMed ID: 1319975
[TBL] [Abstract][Full Text] [Related]
33. Electrocardiographic effects of an Ephedra-Free, multicomponent weight-loss supplement in healthy volunteers.
Min B; McBride BF; Kardas MJ; Ismali A; Sinha V; Kluger J; White CM
Pharmacotherapy; 2005 May; 25(5):654-9. PubMed ID: 15899726
[TBL] [Abstract][Full Text] [Related]
34. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.
Finer N; James WP; Kopelman PG; Lean ME; Williams G
Int J Obes Relat Metab Disord; 2000 Mar; 24(3):306-13. PubMed ID: 10757623
[TBL] [Abstract][Full Text] [Related]
35. Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program.
Volpe SL; Huang HW; Larpadisorn K; Lesser II
J Am Coll Nutr; 2001 Aug; 20(4):293-306. PubMed ID: 11506057
[TBL] [Abstract][Full Text] [Related]
36. Lycium barbarum increases caloric expenditure and decreases waist circumference in healthy overweight men and women: pilot study.
Amagase H; Nance DM
J Am Coll Nutr; 2011 Oct; 30(5):304-9. PubMed ID: 22081616
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of a novel herbal formulation for weight loss demonstrated in a 16-week randomized, double-blind, placebo-controlled clinical trial with healthy overweight adults.
Dixit K; Kamath DV; Alluri KV; Davis BA
Diabetes Obes Metab; 2018 Nov; 20(11):2633-2641. PubMed ID: 29923305
[TBL] [Abstract][Full Text] [Related]
38. The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension.
Tremblay A; Chaput JP; Bérubé-Parent S; Prud'homme D; Leblanc C; Alméras N; Després JP
Eur J Clin Pharmacol; 2007 Feb; 63(2):123-34. PubMed ID: 17200837
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of Euiiyin-tang in Korean women with obesity: A randomized, double-blind, placebo-controlled, multicenter trial.
Cheon C; Song YK; Ko SG
Complement Ther Med; 2020 Jun; 51():102423. PubMed ID: 32507436
[TBL] [Abstract][Full Text] [Related]
40. Weight reduction effects of a black soy peptide supplement in overweight and obese subjects: double blind, randomized, controlled study.
Kwak JH; Ahn CW; Park SH; Jung SU; Min BJ; Kim OY; Lee JH
Food Funct; 2012 Oct; 3(10):1019-24. PubMed ID: 22739624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
